Latest news

Atossa Therapeutics, Inc. (NASDAQ:ATOS), a clinical stage biopharmaceutical company developing innovative proprietary medicines to address significant unmet need in cancer, today announces that the United States Patent

  On Wednesday, 258 companies hit new 52-week lows.

  On Thursday, 241 companies hit new 52-week lows.

  Tuesday's session saw 167 companies set new 52-week lows.

  During Monday's session, 49 companies made new 52-week lows.

Atossa Genetics (NASDAQ:ATOS) reported quarterly losses of $(0.06) per share. This is a 50 percent decrease over losses of $(0.04) per share from the same period last year.

-Reuters

  Monday saw 825 companies set new 52-week lows.

  On Thursday, 1076 companies hit new 52-week lows.

  On Wednesday, 340 stocks hit new 52-week lows.